Delivery Order SPE2DR25D9168-SPE2DR26FCSM8

<p>The Defense Logistics Agency issued a $72,615.58 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for JAKAFI 10 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group is a woman-owned small business. Place of performance is Park Ridge, Illinois. Ultimate completion date is March 3, 2026. The order is priced firm fixed price with no set-aside designation.</p>

<p>The Defense Logistics Agency issued a $25,165.90 delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for JAKAFI 15 mg tablets (60-count units) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order has a firm fixed-price structure with an ultimate completion date of March 11, 2026.</p>

<p>The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, for $12,720.92 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of JAKAFI 5 mg tablets (60-count units).</p> <p>DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The ultimate completion date is February 25, 2026. The order is firm fixed price with no set-aside designation.</p>

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 25, 2026, for JAKAFI 15 mg tablets (60-count units) with a ceiling value of $12,582.95 under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. The order is issued under PPV-G GEN V, the Defense Logistics Agency's single-award indefinite delivery contract (awarded to DMS Pharmaceutical Group on...

The Defense Logistics Agency issued a $25,441.84 delivery order to DMS Pharmaceutical Group Inc. on April 21, 2026, for JAKAFI 5 mg tablets (60-count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical is a woman-owned small business serving as the sole regional prime vendor under PPV-G GEN V, a $30.3 billion Defense Logistics Agency acquisition strategy for branded and generic prescription drugs, biologics, over-the-counter medications, vaccines,...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on April 1, 2026, for JAKAFI 15 mg tablets with a ceiling value of $25,165.90 and ultimate completion date of April 2, 2026. The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a single-award indefinite delivery contract. Place of performance is Park Ridge, IL. DMS Pharmaceutical Group,...

The Defense Logistics Agency issued a $16,526.95 delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for JAKAFI 10 mg tablets (60-count). PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business...

The Defense Logistics Agency issued a $50,653.12 delivery order to DMS Pharmaceutical Group Inc. on March 27, 2026, for JAKAFI 10 mg tablets (60-count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order has a firm fixed price and an ultimate completion date of March 30, 2026. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery...

The Defense Logistics Agency issued a $50,883.68 delivery order to DMS Pharmaceutical Group Inc. on April 16, 2026, for JAKAFI 5 mg tablets (60 count) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). DMS Pharmaceutical is a woman-owned small business holding the single-award indefinite delivery contract SPE2DX under PPV-G GEN V, which carries a $499.999 billion ceiling and runs through December 31, 2036. Place of performance is Park Ridge, Illinois. The order...

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 26, 2026, for $50,492.46 (firm fixed price) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for supply of JAKAFI 10 mg tablets (60-count units). The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned...